STAT3 and glioblastoma: Among the tyrosine phosphatases, the tumor suppressor PTPRD is one of those often inactivated by deletion (>50% of cases), whose loss of expression promotes gliomagenesis through aberrant STAT3 activation (21) and is related with poor prognosis in GBM patients.